Early diagnosis and treatment of pancreatic cancer offer the best odds of beating the disease. Unfortunately, there is still no screening test, such as a blood test, that can reliably detect ...

Pancreatic ductal adenocarcinoma (PDAC) is associated with several genetic syndromes. However, the molecular mechanism underlying PDAC progression is still unknown. In this study, we showed that ...

Vincent Picozzi, MD, discusses findings from the phase 3 trial PANOVA-3 of TTFields with gemcitabine and nab-paclitaxel in locally advanced pancreatic cancer.